These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

777 related articles for article (PubMed ID: 35504171)

  • 1. Skeletal muscle mass and abdominal obesity are independent predictors of hepatic steatosis and interact to predict ten-year cardiovascular disease incidence: Data from the ATTICA cohort study.
    Kouvari M; Polyzos SA; Chrysohoou C; Skoumas J; Pitsavos CS; Panagiotakos DB; Mantzoros CS
    Clin Nutr; 2022 Jun; 41(6):1281-1289. PubMed ID: 35504171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease.
    Gan D; Wang L; Jia M; Ru Y; Ma Y; Zheng W; Zhao X; Yang F; Wang T; Mu Y; Zhu S
    Clin Nutr; 2020 Apr; 39(4):1124-1130. PubMed ID: 31053512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A 7-Year Longitudinal Study.
    Kim G; Lee SE; Lee YB; Jun JE; Ahn J; Bae JC; Jin SM; Hur KY; Jee JH; Lee MK; Kim JH
    Hepatology; 2018 Nov; 68(5):1755-1768. PubMed ID: 29679374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Skeletal Muscle Mass Accompanied by Abdominal Obesity Additively Increases the Risk of Incident Type 2 Diabetes.
    Jun JE; Lee SE; Lee YB; Kim G; Jin SM; Jee JH; Kim JH
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1173-1180. PubMed ID: 36394524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive effect of low skeletal muscle mass and abdominal obesity on coronary artery calcification.
    Jun JE; Kang M; Jin SM; Kim K; Hwang YC; Jeong IK; Kim JH
    Eur J Endocrinol; 2021 May; 184(6):867-877. PubMed ID: 33852417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mediterranean diet is inversely associated with steatosis and fibrosis and decreases ten-year diabetes and cardiovascular risk in NAFLD subjects: Results from the ATTICA prospective cohort study.
    Kouvari M; Boutari C; Chrysohoou C; Fragkopoulou E; Antonopoulou S; Tousoulis D; Pitsavos C; Panagiotakos DB; Mantzoros CS;
    Clin Nutr; 2021 May; 40(5):3314-3324. PubMed ID: 33234342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal muscle mass in relation to 10 year cardiovascular disease incidence among middle aged and older adults: the ATTICA study.
    Tyrovolas S; Panagiotakos D; Georgousopoulou E; Chrysohoou C; Tousoulis D; Haro JM; Pitsavos C
    J Epidemiol Community Health; 2020 Jan; 74(1):26-31. PubMed ID: 31712252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes.
    Hashimoto Y; Osaka T; Fukuda T; Tanaka M; Yamazaki M; Fukui M
    Endocr J; 2016 Oct; 63(10):877-884. PubMed ID: 27397679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Fatty Liver Disease in The Rotterdam Study: About Muscle Mass, Sarcopenia, Fat Mass, and Fat Distribution.
    Alferink LJM; Trajanoska K; Erler NS; Schoufour JD; de Knegt RJ; Ikram MA; Janssen HLA; Franco OH; Metselaar HJ; Rivadeneira F; Darwish Murad S
    J Bone Miner Res; 2019 Jul; 34(7):1254-1263. PubMed ID: 31074909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes.
    Choe EY; Lee YH; Choi YJ; Huh BW; Lee BW; Kim SK; Kang ES; Cha BS; Lee EJ; Huh KB; Younossi ZM
    J Gastroenterol Hepatol; 2018 May; 33(5):1082-1091. PubMed ID: 28990251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Association of Sarcopenia and Visceral Obesity with Lean Nonalcoholic Fatty Liver Disease in Chinese Patients with Type 2 Diabetes Mellitus.
    Zhang X; He Z; Si Q; Hu X; Yang L; Gu X; Du L; Wang L; Pan L; Li Y; Li J; Yang B; Gu X
    J Diabetes Res; 2022; 2022():2229139. PubMed ID: 36387941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appendicular Skeletal Muscle Mass to Visceral Fat Area Ratio Predicts Hepatic Morbidities.
    Han E; Lee YH; Ahn SH; Cha BS; Kim SU; Lee BW
    Gut Liver; 2024 May; 18(3):509-519. PubMed ID: 38013477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-invasive tools for liver steatosis and steatohepatitis predict incidence of diabetes, cardiovascular disease and mortality 20 years later: The ATTICA cohort study (2002-2022).
    Kouvari M; Chrysohoou C; Damigou E; Barkas F; Kravvariti E; Liberopoulos E; Tsioufis C; Sfikakis PP; Pitsavos C; Panagiotakos D; Mantzoros CS;
    Clin Nutr; 2024 Mar; 43(3):900-908. PubMed ID: 38387279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort.
    Choe HJ; Lee H; Lee D; Kwak SH; Koo BK
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):260-269. PubMed ID: 36403577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.
    Arvind A; Henson JB; Osganian SA; Nath C; Steinhagen LM; Memel ZN; Donovan A; Balogun O; Chung RT; Simon TG; Corey KE
    Hepatol Commun; 2022 Feb; 6(2):309-319. PubMed ID: 34558862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
    Fukuda T; Bouchi R; Takeuchi T; Tsujimoto K; Minami I; Yoshimoto T; Ogawa Y
    Cardiovasc Diabetol; 2018 Apr; 17(1):55. PubMed ID: 29636045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-Related Decrease in Skeletal Muscle Mass Is an Independent Risk Factor for Incident Nonalcoholic Fatty Liver Disease: A 10-Year Retrospective Cohort Study.
    Lee MJ; Kim EH; Bae SJ; Kim GA; Park SW; Choe J; Jung CH; Lee WJ; Kim HK
    Gut Liver; 2019 Jan; 13(1):67-76. PubMed ID: 30037166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal muscle mass to visceral fat area ratio as a predictor of NAFLD in lean and overweight men and women with effect modification by sex.
    Cho Y; Chang Y; Ryu S; Jung HS; Kim CW; Oh H; Kim MK; Sohn W; Shin H; Wild SH; Byrne CD
    Hepatol Commun; 2022 Sep; 6(9):2238-2252. PubMed ID: 35503803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased body weight and central adiposity markers are positively associated with the 20-year incidence of cardiovascular disease: The ATTICA epidemiological study (2002-2022).
    Georgoulis M; Damigou E; Chrysohoou C; Barkas F; Kravvariti E; Tsioufis C; Pitsavos C; Liberopoulos E; Sfikakis PP; Panagiotakos DB;
    Nutr Res; 2024 Jan; 121():1-15. PubMed ID: 37995411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.